Baxter International Q3 FY2026 results
$25.81+0.27%
Baxter International reported revenue of $2.98 billion, up 5.0% from a year earlier, net income of $294 million and diluted earnings per share of $0.57 against −$0.09 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).
From its quarterly report, filed 29 Oct 2026. Compiled and checked by AapWire.
Q3 FY2026 against Q3 FY2025
Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.
| Measure | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | $2.98B | $2.83B | +5.0% |
| Gross profit | $994.0M | $950.0M | +4.6% |
| Gross margin | 33.4% | 33.5% | −0.1 pts |
| Operating income | $225.0M | $172.0M | +30.8% |
| Operating margin | 7.6% | 6.1% | +1.5 pts |
| Net income | $294.0M | −$46.00M | — |
| Diluted EPS | $0.57 | −$0.09 | — |
| Operating cash flow | $558.0M | $237.0M | +135% |
| Capital expenditure | $110.0M | $111.0M | −0.9% |
| Free cash flow | $448.0M | $126.0M | +256% |
Operating KPIs for the quarter
| KPI | Q3 FY2026 | Change on a year |
|---|---|---|
| Infusion Therapies & Platforms revenue | $1.8B | up 5.3% |
| Care & Connectivity Solutions revenue | $498.0M | up 5.3% |
| Advanced Surgery revenue | $342.0M | up 11.8% |
| Front Line Care revenue | $308.0M | up 2.7% |
| Medical Products & Therapies revenue | $2.1B | up 6.3% |
| Healthcare Systems & Technologies revenue | $806.0M | up 4.3% |
| United States revenue | $1.6B | up 3.3% |
| International revenue | $1.4B | up 7.0% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sep 2026 | $2.98B | +5.0% | $0.57 |
| Q2 FY2026 | 30 Jun 2026 | $2.96B | +5.3% | $0.24 |
| Q1 FY2026 | 31 Mar 2026 | $2.70B | +2.9% | −$0.03 |
| Q4 FY2025 | 31 Dec 2025 | $2.97B | +8.0% | −$2.20 |
| Q3 FY2025 | 30 Sep 2025 | $2.83B | +5.0% | −$0.09 |
| Q2 FY2025 | 30 Jun 2025 | $2.81B | +4.3% | $0.18 |
| Q1 FY2025 | 31 Mar 2025 | $2.63B | +5.4% | $0.25 |
| Q4 FY2024 | 31 Dec 2024 | $2.75B | +0.9% | −$1.00 |
More on Baxter International: financial statements · revenue · earnings per share
BAX's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.
